PMC:7696151 / 1831-2123 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"53","span":{"begin":41,"end":69},"obj":"Disease"},{"id":"58","span":{"begin":103,"end":110},"obj":"Chemical"},{"id":"61","span":{"begin":119,"end":126},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:D008180"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:D011803"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D008288"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"gan to be also used for the treatment of systemic lupus erythematosus [1,2,3].\nThe increasing need for quinine, due to malaria diffusion, led the pharmaceutical industry to the creation of a synthetic molecule. In 1934 Johann (Hans) Andersag and co-workers at the Bayer I.G. Farbenindustrie i"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":41,"end":69},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002725"}],"text":"gan to be also used for the treatment of systemic lupus erythematosus [1,2,3].\nThe increasing need for quinine, due to malaria diffusion, led the pharmaceutical industry to the creation of a synthetic molecule. In 1934 Johann (Hans) Andersag and co-workers at the Bayer I.G. Farbenindustrie i"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T18","span":{"begin":79,"end":210},"obj":"Sentence"},{"id":"T19","span":{"begin":211,"end":274},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"gan to be also used for the treatment of systemic lupus erythematosus [1,2,3].\nThe increasing need for quinine, due to malaria diffusion, led the pharmaceutical industry to the creation of a synthetic molecule. In 1934 Johann (Hans) Andersag and co-workers at the Bayer I.G. Farbenindustrie i"}